Comparing The Effect Of The SGLT-2 Inhibitors And DPP-4 Inhibitor Combined Therapy With Sulphonylureas And Metformin Combined Therapy In Patients With Type 2 Diabetic Nephropathy. (2023). Journal of Pharmaceutical Negative Results, 498-502. https://doi.org/10.47750/pnr.2023.14.04.59